phase readout

NCT07512596: Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

NOT_YET_RECRUITINGupdated 2mo ago

community read0 votes

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE2. Conditions: Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

view source ↗

NCT07512596: Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Report a data issue

comments(0)